Aug 2026· Biotropika Journal of Tropical Biology· Vol 14, pp. 235-243· 0 citations
TL;DR
Results suggest that, within the tested range, variation in IPTG concentration does not significantly influence JSU protein expression under the applied conditions, and further optimisation, including a broader range of inducer concentrations and induction durations, is recommended to enhance the production of soluble, functional JSU protein.
Abstract
Biotechnology frequently employs Escherichia coli to produce recombinant proteins. However, its efficiency is strongly influenced by induction conditions, particularly the quantity of isopropyl ?-D-1-thiogalactopyranoside (IPTG). This study aimed to evaluate the effect of different IPTG concentrations on the expression of recombinant Jembrana Superficial Unit (JSU) protein in E. coli BL21. The JSU gene cloned into the pET21a vector was induced at 37°C for 1 hour using three IPTG concentrations (0.3, 0.6, and 0.9 mM), each performed in triplicate. SDS-PAGE analysis confirmed successful expression of the recombinant JSU protein, indicated by a distinct band at approximately 37 kDa, consistent with its predicted molecular weight. Bacterial cells were lysed by freeze–thaw, and protein expression levels were quantified by spectrophotometry from optical density measurements and expressed in arbitrary units. Statistical analysis using one-way ANOVA, following confirmation of data normality and homogeneity of variance, revealed mean expression levels of 1.69 ± 0.15, 1.59 ± 0.11, and 1.76 ± 0.28 a.u. for 0.3, 0.6, and 0.9 mM IPTG, respectively, indicating a non-linear trend with a modest increase at the highest concentration. Nevertheless, there were no statistically significant differences between the treatments (p>0.05). These findings suggest that, within the tested range, variation in IPTG concentration does not significantly influence JSU protein expression under the applied conditions. Further optimisation, including a broader range of inducer concentrations and induction durations, is recommended to enhance the production of soluble, functional JSU protein.
Recombinant expression of Mycobacterium tuberculosis antigen 85B (Ag85B) in Escherichia coli is frequently limited by poor solubility and accumulation of the target protein in inclusion bodies. Fusion to thioredoxin (Trx) can improve solubility; however, subsequent removal of the fusion partner using commercial proteas...
N. Tleumbetova, Ж. Ж. Марат, Л. А. Ибрагимова et al.· Experimental biology· 0 citations
Ovalbumin (OVA) is a major egg white protein with a balanced amino acid profile and high digestibility, making it valuable for pharmaceutical, nutritional, and health applications. Recombinant production of ovalbumin provides a sustainable and consistent protein source that may reduce allergenic risks and offer alterna...
Miryam Madeleine Therese, Antonius Suwanto, N. Mubarik· Hayati Journal of Bioscience...· 0 citations
Keratinases are specialized proteases capable of degrading recalcitrant keratin and have attracted considerable interest for environmentally sustainable bioprocessing. In this study, a keratinase gene from Bacillus tequilensis strain YIV, isolated from tannery waste in Kasur, Pakistan, was cloned, expressed, and charac...
Noor e Hira, I. Haq, M. Aftab· International Journal of Bio...· 0 citations
The production of recombinant biopharmaceuticals is a billion-dollar industry, with numerous high-value proteins expressed in the bacterium Escherichia coli. Many recombinant protein production (RPP) systems enable the synthesis and purification of large amounts of soluble recombinant protein. However, such systems are...
Alexandra E. Trigg, Parisa Pordelkhaki, K. М. Klimova et al.· New Biotechnology· 0 citations
Our previous immunoproteomic studies on patients with acute brucellosis identified outer membrane protein 25 (Omp25) of Brucella melitensis as one of the immunogenic antigens, indicating its potential to be used as a diagnostic marker and a tool to differentiate acute and chronic human brucellosis. Expression and purif...
Harshita Mogaveera, Sudipta Patra, N. Pati et al.· Current Protocols· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.